First consumer-facing cannabis awards as voted by over 150 Canadian cannabis retail budtenders
Toronto, Canada, December 10, 2020 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce its Color Cannabis cultivar, Pedro’s Sweet Sativa, was awarded Top Sativa Flower in Canada. Chosen by over 150 retail budtenders from across the country, the awards were organized by KIND Magazine, Canada’s pre-eminent premium cannabis lifestyle magazine.
The list of winners is available in the publication’s December 2020 issue with an estimated circulation of 1.2 million readers. Budtenders from licensed cannabis retail stores throughout Canada were invited to nominate and vote for their favourite cannabis products and brands across 22 separate categories in the largest consumer-facing cannabis awards in Canadian history.
“Today’s cannabis consumers are extremely discerning and we are honoured that our terpene-rich Pedro’s Sweet Sativa continues to impress as an award-winning cultivar,” said Angelo Tsebelis, Chief Executive Officer, WeedMD. “We are incredibly proud of all of our teams who have worked diligently to develop our Color Cannabis products and provide budtenders with information about the value of our terpene-rich profiles.”
“Quality cultivation, time-tested genetics and post-harvest craftmanship are the foundation for providing customers with the ultimate cannabis experience,” said Curtis Wallace, Head of Cultivation, WeedMD. “We applaud our nation’s expert budtenders, and are honoured that they have chosen Pedro’s Sweet Sativa, as Canada’s best sativa flower.”
“Our budtenders have built their careers around their love for cannabis and mission to educate consumers. We wanted to create ‘the people’s awards,’ and challenged our distribution partners to tell us their personal opinions on Canadian cannabis in 2020,” said Joshua Nagel, KIND Magazine publisher. “We are thrilled to include Color Cannabis-branded Pedro’s Sweet Sativa in this prime position as top sativa.”
The distinction validates the Company’s craft approach to cultivation. Quality-driven practices include cultivating in 10,000-square-foot grow rooms of its hybrid greenhouse, hang-drying, curing, hand-trimming and packing in nitrogen-infused packages. WeedMD’s Color Cannabis flower portfolio is built around the Company’s premium cultivars, including Ghost Train Haze, Mango Haze, Pedro’s Sweet Sativa and its newest cultivar, Black Sugar Rose, now available in Ontario retail markets. Read more about WeedMD’s craft approach to cultivation here.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator based in Bowmanville, ON, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well, as six provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.
Follow WeedMD On:
Follow Color Cannabis:
For further information, please contact:
For Investor Enquiries:
KCSA Strategic Communications
For Media Enquiries:
Communications & Corporate Affairs
To learn more, visit us at www.weedmd.com
Forward Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE